S

SphingoTec

41 employees

SphingoTec develops innovative biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Biomarker discovery
Acute care diagnostics
Sepsis

Date founded

2002

Funding rounds raised

Total raised

$1.6M

from 2 investors over 2 rounds

S

SphingoTec raised $1.6M on March 14, 2023

Investors: HBM Partners AG

S

SphingoTec raised undisclosed on April 22, 2022

Investors: HBM Partners AG

FAQ